Who Should Not Get a Chemical Peel: A Contraindications Reference

Most people can safely get a chemical peel after a thorough clinical consultation, but certain medical conditions, medications, and healing profiles require postponing or avoiding treatment entirely. Absolute contraindications include active viral or bacterial skin infections (such as herpes simplex cold sores), pregnancy or breastfeeding, recent oral isotretinoin use within 6 to 12 months for medium and deep peels, and a personal or family history of keloid or hypertrophic scarring in the treatment area. Relative contraindications depend heavily on the specific acid formulation and peel depth, requiring careful professional judgment, pre-treatment skin priming, and individualized patch testing.

Because chemical resurfacing works by delivering a controlled chemical injury to the epidermis and dermis, the skin must possess normal wound-healing capacity to regenerate healthy tissue. When systemic health, barrier integrity, or cellular turnover is compromised, the risk of permanent scarring, persistent infection, or severe pigmentary alteration increases dramatically. A reputable clinician will always review your medical history, current prescriptions, and aesthetic goals before recommending any peel protocol.

Absolute vs Relative Contraindications by Peel Depth

Contraindications to chemical peeling are divided into two fundamental clinical categories. Absolute contraindications represent physiological states where the danger of catastrophic complications far outweighs any cosmetic benefit, making chemical peeling strictly prohibited. Relative contraindications represent circumstances where treatment may proceed under modified clinical protocols, such as selecting a milder acid, lowering the concentration, buffering the pH, or requiring medical pre-treatment.

Contraindication or Condition	Superficial Peels (AHA, BHA, Enzyme)	Medium-Depth Peels (TCA, Jessner)	Deep Phenol Peels (Baker-Gordon)
Pregnancy and Breastfeeding	Relative (Glycolic, Lactic permitted; Salicylic avoided)	Absolute (Risk of systemic transdermal absorption)	Absolute (Strictly contraindicated due to cardiotoxicity)
Oral Isotretinoin (Accutane) within 6-12 Months	Relative (Superficial AHAs permitted per ASDS consensus)	Absolute (Postpone 6 to 12 months due to scarring risk)	Absolute (Postpone minimum 12 months; impaired adnexal healing)
Active Herpes Simplex (Cold Sores) or Impetigo	Absolute until completely healed	Absolute (Requires pre-procedure antiviral prophylaxis)	Absolute (Risk of widespread disseminated herpes eruption)
Keloid or Hypertrophic Scarring History	Relative (Proceed with mild alpha hydroxy acids with caution)	Relative to Absolute (High risk of irreversible scar formation)	Absolute (Strictly prohibited on chest, neck, or jawline)
Fitzpatrick Skin Phototypes IV through VI	Safe with appropriate priming (Mandelic, Salicylic, Lactic)	High Caution (Requires hydroquinone priming; test spot mandatory)	Absolute (Severe risk of permanent porcelain hypopigmentation)
Recent Facial Surgery, Laser, or Facelift (Within 3-6 Months)	Relative (Safe once surgical incisions fully mature)	Absolute until complete dermal microcirculation recovers	Absolute (Risk of full-thickness skin flap necrosis)
Aspirin or Salicylate Allergy	Absolute for Salicylic Acid; safe for Glycolic/Lactic	Safe if formulation excludes salicylic acid (pure TCA)	Safe (Formulations rely on carbolic acid, not salicylates)
Active Inflammatory Flares (Eczema, Psoriasis, Rosacea)	Absolute in treatment zone until barrier resolves	Absolute (Can trigger severe Koebner phenomenon and barrier collapse)	Absolute (Resurfacing prohibited on compromised tissue)
Cardiac Arrhythmia, Renal Disease, or Hepatic Failure	Safe (Zero systemic cardiac or renal absorption)	Safe (TCA neutralizes within dermal proteins)	Absolute (Phenol is directly cardiotoxic, nephrotoxic, and hepatotoxic)
Inability to Comply with Strict Sun Protection	Relative (Requires patient commitment to daily SPF 30+)	Absolute (Guaranteed post-inflammatory hyperpigmentation)	Absolute (Direct sunlight during healing causes severe dyschromia)

Systemic Medications and Oral Isotretinoin Timing

Among all prescription medications, oral isotretinoin (commonly known historically by brand names such as Accutane) demands the most rigorous clinical scrutiny before chemical peeling. Isotretinoin suppresses sebaceous gland activity, temporarily alters epidermal differentiation, and inhibits normal re-epithelialization from the pilosebaceous units. In medium-depth and deep chemical peels, the newly resurfaced epidermis must regenerate from deep follicular adnexal structures. If these structures cannot proliferate properly, delayed re-epithelialization, full-thickness ulceration, and hypertrophic or keloidal scarring can develop.

Historically, dermatologists mandated a strict 12-month waiting period following the completion of oral isotretinoin before any cosmetic resurfacing could be performed. In recent years, a landmark clinical consensus published by the American Society for Dermatologic Surgery (ASDS) updated this guidance: superficial chemical peels (such as low-concentration glycolic acid, lactic acid, or salicylic acid) are considered safe for patients currently taking or recently finished with isotretinoin, provided active barrier dermatitis is absent. However, for medium-depth peels (such as 35% trichloroacetic acid combined with Jessner solution) and deep phenol peels, clinicians still enforce a conservative 6 to 12 month waiting period to safeguard skin barrier biology.

Other systemic medications also affect peel safety. Patients taking photosensitizing pharmaceuticals (such as doxycycline, minocycline, thiazide diuretics, or nonsteroidal anti-inflammatory drugs) experience significantly heightened cellular vulnerability to ultraviolet radiation. If these patients undergo chemical peeling, post-procedure sun exposure can trigger severe phototoxic reactions and recalcitrant post-inflammatory hyperpigmentation. Similarly, long-term systemic corticosteroids or immunosuppressive drugs impair fibroblast proliferation and host defenses, creating a substantial risk of secondary wound infection.

Viral, Bacterial, and Fungal Infection Boundaries

Chemical resurfacing must never be performed on skin hosting an active infectious process. Performing a peel over open sores, impetigo, folliculitis, or active viral eruptions mechanically spreads pathogens across the entire facial surface, converting a localized lesion into a catastrophic, full-face infectious crisis.

Herpes simplex virus (HSV-1) is the most common and clinically treacherous viral pathogen encountered in facial aesthetic procedures. The physical thermal and chemical trauma of an acid peel provokes intense neurogenic stimulation, rapidly triggering latent virus residing within the trigeminal ganglion. If an HSV reactivation occurs while the skin is de-epithelialized and raw, the virus can spread uncontrollably across the entire treated zone, a devastating complication known as herpetic keratitis or eczema herpeticum. This can cause widespread punched-out erosions, secondary bacterial infection, and permanent pitted scars. For any patient with a personal history of cold sores, board-certified clinicians prescribe preventative oral antiviral prophylaxis (such as valacyclovir 500 mg to 1,000 mg daily) starting 1 to 2 days prior to medium or deep peels and continuing until complete re-epithelialization occurs.

Bacterial infections, primarily caused by Staphylococcus aureus or Streptococcus pyogenes, also represent absolute contraindications. If impetigo, pustular folliculitis, or active cystic lesions are present, peeling must be delayed until the infection has cleared following targeted antimicrobial therapy. Similarly, active facial fungal infections, such as tinea faciei, will worsen if treated with acidic exfoliants.

Pregnancy, Lactation, and Systemic Chemical Absorption

Elective cosmetic procedures are routinely deferred during pregnancy, but the biological reasons vary depending on the chemical agent involved. The primary concern is transdermal absorption of the chemical agent into maternal circulation, potentially crossing the placenta to affect fetal development or passing into breast milk during lactation.

Salicylic acid, a lipophilic beta hydroxy acid, is chemically related to aspirin (acetylsalicylic acid). While small amounts applied as a localized rinse-off cleanser carry negligible risk, full-face or body peeling with high-concentration salicylic acid (20% to 30%) results in measurable systemic absorption. Because high systemic salicylate levels in pregnancy are associated with adverse fetal outcomes, salicylic acid peels are contraindicated for pregnant and nursing mothers. Deep phenol peels are strictly prohibited under all circumstances due to profound maternal and fetal toxicity.

Conversely, superficial alpha hydroxy acids (such as glycolic acid and lactic acid) undergo negligible systemic penetration and are metabolized by normal cellular pathways. While low-strength AHA treatments may be physically safe, pregnancy hormones (estrogen and progesterone) stimulate melanocytes, dramatically increasing susceptibility to melasma (the mask of pregnancy). Applying an acid peel to hormonally primed skin carries an unpredictable risk of triggering or worsening hyperpigmentation. For this reason, most dermatologists advise waiting until several months postpartum and after weaning before pursuing elective peeling regimens. For detailed guidance on maternity protocols, review our reference on chemical peels while pregnant.

Scarring Diathesis, Wound Healing Biology, and Keloid Risks

The core objective of a chemical peel is to stimulate dermal neocollagenesis through controlled tissue destruction. In healthy individuals, the wound-healing cascade progresses smoothly through inflammation, tissue proliferation, and matrix remodeling, depositing organized type I and type III collagen. However, in individuals with a genetic predisposition toward abnormal wound healing, this process malfunctions.

Patients with a personal or first-degree family history of keloid scarring or hypertrophic scar formation should approach chemical peels with extreme caution. Keloid scars are fibroproliferative lesions that extend beyond the boundaries of the original wound, caused by unchecked fibroblast activity and excessive extracellular matrix deposition. While superficial peels that remain strictly within the stratum corneum and epidermis carry very low keloid risk, any medium-depth or deep peel that damages the papillary or reticular dermis can trigger spontaneous keloid formation.

Anatomical location also matters immensely. The facial skin is richly supplied with sebaceous glands and has exceptional regenerative microcirculation, whereas the neck, chest (décolletage), and shoulders have significantly fewer pilosebaceous units and thinner dermis. Performing medium-depth or deep peels on the neck or chest in a patient with a scarring history frequently results in permanent, disfiguring hypertrophic bands. Before consenting to any peel deeper than a mild AHA, patients must disclose past scarring behavior, including how skin heals after ear piercings, surgical incisions, or accidental lacerations.

Fitzpatrick Skin Phototypes (IV through VI) and Dyschromia Management

Skin color and ethnic heritage represent one of the most critical determinants of peel safety. Dermatology categorizes skin into Fitzpatrick phototypes I through VI based on melanin content and constitutional response to ultraviolet radiation. Phototypes I to III represent fair skin that burns easily, whereas phototypes IV to VI represent olive, brown, and deeply pigmented skin (including Mediterranean, Hispanic, Asian, Middle Eastern, and African descent).

In richly pigmented skin, melanocytes are biologically hyper-reactive. Any mechanical or chemical trauma that creates cutaneous inflammation can signal melanocytes to overproduce melanin, depositing pigment irregularly throughout the basal layer and upper dermis. This condition, known as post-inflammatory hyperpigmentation (PIH), produces stubborn, dark brown patches that can persist for months or years. Even more devastating is post-inflammatory hypopigmentation, where deep acid injury permanently destroys melanocytes, leaving white, porcelain-like patches that cannot produce pigment again.

Having darker skin does not mean you cannot have a chemical peel, but it completely changes the rulebook:

• Deep Phenol Peels Are Strictly Prohibited: Phenol toxicly lyses melanocytes and reliably causes permanent bleaching of darker skin, creating a stark, unnatural line of demarcation between treated and untreated areas.
• Superficial Exfoliants Are Safe When Chosen Wisely: Mandelic acid (an AHA with a larger molecular structure that penetrates slowly and evenly), lactic acid (hydrating and gentle), and salicylic acid (anti-inflammatory) are exceptionally safe for Fitzpatrick IV through VI when formulated correctly.
• Pre-Peel Priming Is Mandatory: Patients with skin of color must prime their skin for 2 to 4 weeks before a peel using tyrosinase inhibitors (such as azelaic acid, kojic acid, tranexamic acid, or prescription hydroquinone) to calm melanocyte activity.
• Mandatory Test Patching: An ethical practitioner will always perform a small test spot behind the ear or along the jawline to observe the individual pigmentary response before treating the entire face.

Read our specialized guide on chemical peels for dark skin to understand depth parameters and tailored acid selection.

Pre-Treatment Sensitizers: Retinoids, Exfoliants, and Facial Waxing

Contraindications are not always chronic medical diseases; they are frequently temporary, lifestyle-induced compromises of the skin barrier. Over-the-counter and prescription topical skincare products can dramatically alter how chemical acids penetrate the skin.

Topical retinoids (including tretinoin, tazarotene, adapalene, and high-strength over-the-counter retinol) thin the stratum corneum and accelerate cellular mitosis. If a patient applies tretinoin up until the morning of a chemical peel, the peeling solution will penetrate far deeper, faster, and more erratically than intended, turning what was planned as a superficial peel into an unintended, blistering medium-depth burn. Clinicians instruct patients to discontinue all topical retinoids, alpha hydroxy acids, beta hydroxy acids, and physical facial scrubs at least 3 to 7 days prior to treatment.

Physical epilation procedures represent another critical temporary contraindication. Facial waxing, threading, electrolysis, and chemical depilatory creams physically strip off layers of corneocytes. Receiving an acid peel within 7 to 10 days of facial waxing will cause severe localized acid burns, blistering, and stripe-like post-inflammatory hyperpigmentation along the waxed areas. Always allow at least one to two weeks between any epilation procedure and a professional chemical peel.

Deep Resurfacing Organ Safety: Cardiac, Hepatic, and Renal Factors

While superficial and medium-depth peels remain localized to the cutaneous layers, deep chemical peels using the Baker-Gordon phenol formula represent full surgical procedures with systemic physiological impacts. Phenol (carbolic acid) is readily absorbed through the facial skin directly into the bloodstream, where it is detoxified by the liver and excreted by the kidneys.

Rapid systemic absorption of phenol can provoke fatal cardiac arrhythmias, including ventricular tachycardia, ventricular fibrillation, and severe bradycardia. For this reason, deep phenol peels are strictly contraindicated in patients with a history of cardiac disease, irregular heartbeat, coronary artery disease, renal insufficiency, or liver disease. Deep phenol procedures must always be conducted in an accredited clinical or surgical facility with continuous electrocardiographic (ECG) monitoring, intravenous fluid hydration, pulse oximetry, and staged application over 60 to 90 minutes to allow the kidneys and liver to clear circulating metabolites safely. If you are exploring deeper resurfacing options, review our clinical analysis of phenol peels.

Pre-Peel Medical History Screening: 10 Essential Disclosures

A reputable aesthetic provider relies entirely on the accuracy of your pre-treatment disclosure. Never withhold health information out of fear that your appointment might be rescheduled. Bringing this checklist to your consultation ensures complete clinical transparency:

1. Pregnancy and Nursing Status: Confirm whether you are pregnant, planning to conceive, or currently breastfeeding.
2. Isotretinoin History: State the exact date of your final dose if you have ever taken oral Accutane or generic isotretinoin.
3. Cold Sore and Viral History: Disclose whether you have ever had an oral herpes outbreak or fever blister, even years ago.
4. Prescription Skincare Routine: List every topical active, including tretinoin, hydroquinone, benzoyl peroxide, and steroids.
5. Allergies and Sensitivities: Report any known drug allergies, especially aspirin, salicylates, sulfur, or cosmetic preservatives.
6. Abnormal Scarring Tendencies: Note any personal or family history of keloid scars, thick hypertrophic scars, or poor wound healing.
7. Recent Cosmetic Procedures: Mention any neurotoxin injections, dermal fillers, laser sessions, microneedling, or facial surgery within the past 6 months.
8. Pigmentation Behavior: Describe how your skin behaves after mosquito bites, cuts, or blemishes (do they leave persistent dark brown spots?).
9. Underlying Chronic Conditions: Disclose diagnosed autoimmune disorders, diabetes, connective tissue diseases, or active rosacea and eczema.
10. Upcoming Sun Exposure: Inform your clinician if you have a tropical vacation, outdoor wedding, or heavy sun exposure scheduled within the next 4 weeks.

7 Vital Questions to Ask at Your Clinical Consultation

Patient safety is a collaborative effort between clinician and patient. During your consultation, ask these targeted questions to verify that your provider understands your individual candidacy profile:

• Which specific acid, concentration, and pH are you recommending, and why does this formula suit my skin type? Avoid providers who offer a vague proprietary peel without disclosing the active chemical ingredients.
• Based on my medical history and Fitzpatrick type, what are my personal risks for post-inflammatory hyperpigmentation or scarring? An experienced provider will readily discuss risk mitigation protocols and pre-treatment priming.
• Do I need a prophylactic antiviral prescription prior to this treatment? If you have a cold sore history and are undergoing medium resurfacing, the answer should always be yes.
• What pre-peel priming protocol do I need to follow at home, and how many days before treatment must I stop my active topicals? Clear pre-treatment preparation is essential for even acid penetration and complication prevention. Review our pre-treatment preparation checklist for standard guidelines.
• What will happen if my skin begins to react adversely during the application? Your clinician should clearly explain their neutralization protocol and emergency cooling measures.
• What are the specific warning signs of infection or abnormal healing that should prompt me to call your clinic? Ensure you have 24-hour contact instructions for post-procedure concerns. Check our guide on chemical peel side effects for clear distinctions between normal healing and adverse events.
• What credentials and specialized training do you possess in chemical peeling? Confirm whether your provider is a board-certified dermatologist, plastic surgeon, or licensed aesthetician operating under physician supervision. Our guide on choosing a qualified provider covers licensing standards across states.

Frequently Asked Questions